Thirona is thrilled to have secured €7,5 Million ($8 Million) of financing from HERAN Partners, Borski Fund and the EIC.

Following the second 2023 EIC Accelerator cut-off in March, Thirona is awarded to receive European Innovation Council (EIC) funding.

Thirona’s AI-Based LungQ™AVX Reveals New Potential for Treatment of Vascular Diseases.

Following the growing market demand and recent expansion of RetCAD™, Thirona decided spins it out as per January 1st,

2 abstracts of major importance for advancing the treatment of pulmonary vascular diseases, and pulmonary hypertension in particular, were presented today at ATS 2023 International Conference in Washington by Julien Guiot from CHU de Liège.

Bringing AI into clinical care through integration partnerships with Philips & Incepto.

On November 24th the matchmaking in healthcare event took place, organized by the Netherlands AI coalition

AI significantly increases efficiency in predicting the risk of deterioration of the COVID-19 patient’s condition.

Thirona is awarded ISO 27001 and NEN 7510 certifications.